MR-proADM as a Early Biomarker for DGF and AR in Kidney and Liver Transplantation
Condition(s):Kidney Transplant; Complications; Liver Transplant; ComplicationsLast Updated:November 13, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Kidney Transplant; Complications; Liver Transplant; ComplicationsLast Updated:November 13, 2023Recruiting
Condition(s):Coronary Artery CalcificationLast Updated:August 3, 2023Recruiting
Condition(s):Single Transplant; 5 Years of Follow-up After Transplant, in Which an Attempt Was Made to Suspend ISLast Updated:April 11, 2023Completed
Condition(s):OstomyLast Updated:September 15, 2023Recruiting
Condition(s):Acute Myeloid LeukemiaLast Updated:March 30, 2023Active, not recruiting
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:March 22, 2023Recruiting
Condition(s):Mandibular FlexureLast Updated:February 8, 2023Completed
Condition(s):Breast Haematoma; Breast Cancer; Breast DiseasesLast Updated:December 29, 2022Completed
Condition(s):COVID-19 Pandemic; Transplant-Related DisorderLast Updated:December 20, 2022Completed
Condition(s):Obesity; Obesity, Abdominal; SurgeryLast Updated:September 27, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.